Whitney D. Maxwell, Pharm.D., BCPS

Assistant Professor

CPOS, South Carolina College of Pharmacy

803.777.4715 :: Columbia

Dr. Whitney's Email

Dr. Michael Wyatt

About Dr. Maxwell

Whitney Maxwell, PharmD, is a Clinical Assistant Professor in the Department of Clinical Pharmacy and Outcomes Sciences at the South Carolina College of Pharmacy (SCCP) in Columbia, South Carolina.  She joined the faculty in 2011 after receiving a Doctor of Pharmacy degree from the Medical University of South Carolina in 2008, completing PGY-1 residency training in 2009 at the University of Virginia Health System, and completing a PGY-2 pharmacotherapy specialty residency with an emphasis in family medicine at the University of North Carolina at Chapel Hill in 2010.  She received board certification as a pharmacotherapy specialist in 2009.  Her clinical experience is in the area of Ambulatory Care.  Her research interests include transitions of care, pharmacogenetics, and venous thromboembolism prophylaxis and management. 

Whitney received the South Carolina College of Pharmacy Extra Mile faculty award in 2013.  She currently serves as the coordinator of upstate experiential education for the South Carolina College of Pharmacy, the faculty development coordinator for SCCP’s USC campus, and is the co-advisor for USC’s founding Phi Delta Chi professional fraternity chapter.  Professional organization activities include serving on the South Carolina Society of Health-System Pharmacists Education Committee from 2011-2012 and as the USC Campus Faculty Liaison from 2012-2013.  Whitney has also served on the membership, education, and nominations committees for the American College of Clinical Pharmacy Ambulatory Care PRN.  


Doctor of Pharmacy
Medical University of South Carolina, 2008

PGY1 Pharmacy Practice Residency
University of Virginia Health System, 2010

PGY2 Pharmacotherapy Specialty Residency (Emphasis in Family Medicine)
University of North Carolina at Chapel Hill, 2010

  • Transitions of care
  • Pharmacogenetics
  • Venous thromboembolism prophylaxis and treatment


  • Wilke RA, Ramsey L, Johnson SG, Maxwell WD, et al.  The Clinical Pharmacogenomics Implementation Consortium CPIC guideline for SLCO1B1 and simvastatin-induced myopathy.  Clinical  Pharmacology and Therapeutics 2012;92:112-117. PMID:  22617227
  • Maxwell WD, Bennett CL. Venous Thromboembolism: a Review of Burden, Risk Factors, and Evidence in Support of Thromboprophylaxis in Ambulatory Cancer Patients Receiving Chemotherapy.  Semin Thromb Hemost. 2012;38:759-767.  PMID: 23111863
  • Maxwell WD, Bennett CL.  Will Newer Anticoagulants Improve Therapy Persistence?  Arch Int Med 2012;172(19):1689-1690.
  • Hawes EM, Maxwell WD, Ford SK, Mangun J, Lin FC. Impact of an Outpatient Pharmacist Intervention on Medication Discrepancies and Health Care Resource Utilization in Posthospitalization Care Transitions.  Journal of Primary Care and Community Health. 2013; doi:10.1177/2150131913502489